The Technical Analyst
Aerpio Pharmaceuticals [ARPO]
Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Aerpio Pharmaceuticals Price, Forecast, Insider, Ratings, Fundamentals & Signals
-0.90% $2.20
America/New_York / 27 aug 2021 @ 00:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 53.67 mill |
| EPS: | 0 |
| P/E: | 0 |
| Earnings Date: | N/A |
| SharesOutstanding: | 24.40 mill |
| Avg Daily Volume: | 0.402 mill |
| RATING 2021-08-27 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Sell | |
| Return On Asset: | Sell | |
| DE: | Neutral | |
| P/E: | Neutral | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt | n/a | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE 5.88 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 2.02 - 2.38 ( +/- 8.05%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2021-06-30 | Dalal Anupam | Buy | 7 400 | Common Stock |
| 2021-06-30 | Castelein Caley | Buy | 7 811 | Common Stock |
| 2021-06-30 | Cohen Cheryl | Buy | 8 140 | Common Stock |
| 2021-06-17 | Cohen Cheryl | Buy | 100 000 | Stock Option (Right to Buy) |
| 2021-03-31 | Cohen Cheryl | Buy | 8 020 | Common Stock |
| INSIDER POWER |
|---|
| 0.00 |
| Last 63 transactions |
| Buy: 4 252 497 | Sell: 3 402 072 |
Forecast:
01:40 - $2.35
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $2.20 (-0.90% ) |
| Volume | 0.826 mill |
| Avg. Vol. | 0.402 mill |
| % of Avg. Vol | 205.59 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For ARPO
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
ARPO
Aerpio Pharmaceuticals Inc. is a biopharmaceutical company, which engages in the research and development of treatments for ocular diseases. The company is headquartered in Blue Ash, Ohio and currently employs 27 full-time employees. The firm is focused on developing treatments for ocular disease. Its lead product candidate is AKB-9778. Its other two pipeline programs include AKB-4924 and ARP-1536. AKB-9778 is a small molecule activator of the Tie-2 pathway, which is being developed for the treatment of diabetic retinopathy (DR). AKB-4924 is a selective stabilizer of hypoxia-inducible factor-1 alpha (HIF-1alpha), which is being developed for the treatment of inflammatory bowel disease (IBD). ARP-1536 is a humanized monoclonal antibody directed at the same target as AKB-9778. ARP-1536 binds the extracellular domain of vascular endothelial protein tyrosine phosphatase (VE-PTP) inhibiting its ability to interact with Tie-2. As of April 14, 2017, the Company had completed a Phase II trial of AKB-9778 in 144 patients with diabetic macular edema. As of April 14, 2017, the Company had completed Phase Ia clinical trial in healthy volunteers for AKB-4924.
Last 10 Buy Signals
Latest Press Releases
2021-08-11 16:10:00 - Press Release
Aerpio Reports Second Quarter 2021 Financial Results And Provides Business Update
Cincinnati, aug. 11, 2021 (globe newswire) -- aerpio pharmaceuticals, inc. (“aerpio”) (nasdaq: arpo), a biopharmaceutical company, today reported financial results for the three and six months ended june 30, 2021 and provided a business update.
2021-07-10 13:59:00 - Press Release
Investigation Alert: Halper Sadeh Llp Investigates Onem, Syke, Nete, Chma, Soly, Arpo; Shareholders Are Encouraged To Contact The Firm
New york , july 10, 2021 /prnewswire/ -- halper sadeh llp, a global investor rights law firm, announces it is investigating the following companies: 1life healthcare, inc. (nasdaq: onem) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with iora health. under the terms of the merger, 1life healthcare will acquire iora health in an all-stock transaction.
2021-06-04 09:15:00 - Press Release
Aerpio Provides Second Update On Aadi Bioscience Presentation At The Asco 2021 Virtual Meeting
Cincinnati, june 04, 2021 (globe newswire) -- aerpio pharmaceuticals, inc. (“aerpio”) (nasdaq: arpo) announced that aadi bioscience, inc. (“aadi”), a privately-held biopharmaceutical company focusing on precision therapies for genetically-defined cancers with alterations in mtor pathway genes, today issued a press release disclosing that a poster has been presented at the american society of clinical oncology (asco) 2021 annual meeting. as previously disclosed, on may 16, 2021, aerpio entered into an agreement and plan of merger among aerpio, aadi, and aspen merger subsidiary, inc.
2021-05-21 21:00:00 - Press Release
Shareholder Alert: Monteverde & Associates Pc Announces An Investigation Of Aerpio Pharmaceuticals, Inc. - Arpo
New york, may 21, 2021 /prnewswire/ -- juan monteverde , founder and managing partner at monteverde & associates pc, a national securities firm rated top 50 in the 2018-2020 iss securities class action services report and headquartered at the empire state building in new york city, is investigating aerpio pharmaceuticals, inc. ("arpo" or the "company") (arpo) relating to its proposed merger with aadi bioscience, inc. under the terms of the agreement, arpo shareholders are expected to own 14.7% of the combined company after the closing of the concurrent pipe financing transaction. the investigation focuses on whether aerpio pharmaceuticals, inc. and its board of directors violated securities laws and/or breached their fiduciary duties to the company by 1) failing to conduct a fair process, and 2) whether the transaction is properly valued.
2021-05-20 21:43:00 - Press Release
Aerpio Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, Llc Investigates Merger Of Aerpio Pharmaceuticals, Inc. - Arpo
New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed merger of aerpio pharmaceuticals, inc. (“the company”) (nasdaqgs: arpo) with aadi bioscience, inc. pursuant to which aerpio shareholders will own approximately 14.7% of the combined company following the closing of the concurrent pipe financing. ksf is seeking to determine whether the merger and the process that led t
Latest News
2021-08-30 11:24:42 - InvestorPlace
The 6 Best Penny Stocks to Buy for September
Investing in penny stocks can be an intriguing numbers game. With many stocks to choose from, a handful are bound to be winners.
2021-08-18 09:02:24 - PennyStocks
Top Penny Stocks to Buy? Here's 3 That Investors Are Watching
Why investors are watching these penny stocks right now The post Top Penny Stocks to Buy? Here's 3 That Investors Are Watching appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2021-08-13 13:54:35 - PennyStocks
Best Penny Stocks To Buy Right Now? 5 To Watch Before September
2021-08-11 16:10:00 - GlobeNewsWire
Aerpio Reports Second Quarter 2021 Financial Results and Provides Business Update
CINCINNATI, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company, today reported financial results for the three and six months ended June 30, 2021 and provided a business update.
2021-07-18 17:25:00 - PennyStocks
Penny Stocks to Buy Right Now? 4 For Your Late July Watchlist
Looking For the Best Penny Stocks to Watch in July? Check These 4 Out The post Penny Stocks to Buy Right Now?
2021-07-17 12:45:00 - PennyStocks
Hot Penny Stocks to Buy Now? 6 Reopening Stocks To Watch In July 2021
Reopening penny stocks are showing momentum right now; here's 6 to watch The post Hot Penny Stocks to Buy Now? 6 Reopening Stocks To Watch In July 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2021-07-12 16:58:42 - PennyStocks
Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist
Biotech penny stocks are in focus; here's 4 to watch right now The post Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2021-07-10 13:59:00 - PRNewsWire
INVESTIGATION ALERT: Halper Sadeh LLP Investigates ONEM, SYKE, NETE, CHMA, SOLY, ARPO; Shareholders are Encouraged to Contact the Firm
NEW YORK , July 10, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: 1Life Healthcare, Inc. (NASDAQ: ONEM) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Iora Health. Under the terms of the merger, 1Life Healthcare will acquire Iora Health in an all-stock transaction.
2021-07-08 13:43:01 - Benzinga
Why Aerpio Shares Are Skyrocketing Today
Shares of microcap biopharma Aerpio Pharmaceuticals, Inc. (ARPO) are advancing strongly Thursday on above-average volume. The upside in reaction a positive analyst action.
2021-07-08 12:15:42 - InvestorPlace
DBGI Stock: 13 Things to Know About Digital Brands as Shares Take Off Today
Digital Brands (DBGI) stock is rocketing higher on Thursday after revealing estimated financial data for its upcoming quarter. The post DBGI Stock: 13 Things to Know About Digital Brands as Shares Take Off Today appeared first on InvestorPlace.